Literature DB >> 27723453

Haemophilia B is clinically less severe than haemophilia A: further evidence.

Massimo Franchini1, Pier Mannuccio Mannucci2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27723453      PMCID： PMC5839607          DOI： 10.2450/2016.0158-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  24 in total

1.  Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.

Authors:  K Nagel; I Walker; K Decker; A K C Chan; M K Pai
Journal:  Haemophilia       Date:  2011-02-22       Impact factor: 4.287

Review 2.  Modern haemophilia care.

Authors:  Erik Berntorp; Amy D Shapiro
Journal:  Lancet       Date:  2012-03-27       Impact factor: 79.321

3.  A study of reported factor IX use around the world.

Authors:  J S Stonebraker; P H B Bolton-Maggs; M Brooker; A Farrugia; A Srivastava
Journal:  Haemophilia       Date:  2011-02-07       Impact factor: 4.287

4.  Is VIII worse than IX?

Authors:  Michael Makris
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

Review 5.  Hemophilia: treatment options in the twenty-first century.

Authors:  P M Mannucci
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

6.  The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.

Authors:  T T Biss; A K Chan; V S Blanchette; L N Iwenofu; M McLimont; M D Carcao
Journal:  Haemophilia       Date:  2008-07-14       Impact factor: 4.287

7.  Validation of a composite score for clinical severity of hemophilia.

Authors:  S Schulman; A Eelde; M Holmström; G Ståhlberg; J Odeberg; M Blombäck
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

8.  The history of hemophilia.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Semin Thromb Hemost       Date:  2014-06-09       Impact factor: 4.180

9.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Authors:  Marilyn J Manco-Johnson; Thomas C Abshire; Amy D Shapiro; Brenda Riske; Michele R Hacker; Ray Kilcoyne; J David Ingram; Michael L Manco-Johnson; Sharon Funk; Linda Jacobson; Leonard A Valentino; W Keith Hoots; George R Buchanan; Donna DiMichele; Michael Recht; Deborah Brown; Cindy Leissinger; Shirley Bleak; Alan Cohen; Prasad Mathew; Alison Matsunaga; Desiree Medeiros; Diane Nugent; Gregory A Thomas; Alexis A Thompson; Kevin McRedmond; J Michael Soucie; Harlan Austin; Bruce L Evatt
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

10.  Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Authors:  Johnny Mahlangu; Jerry S Powell; Margaret V Ragni; Pratima Chowdary; Neil C Josephson; Ingrid Pabinger; Hideji Hanabusa; Naresh Gupta; Roshni Kulkarni; Patrick Fogarty; David Perry; Amy Shapiro; K John Pasi; Shashikant Apte; Ivan Nestorov; Haiyan Jiang; Shuanglian Li; Srividya Neelakantan; Lynda M Cristiano; Jaya Goyal; Jurg M Sommer; Jennifer A Dumont; Nigel Dodd; Karen Nugent; Gloria Vigliani; Alvin Luk; Aoife Brennan; Glenn F Pierce
Journal:  Blood       Date:  2013-11-13       Impact factor: 22.113
View more
  3 in total

1.  Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity.

Authors:  Michael Wang; Michael Recht; Neeraj N Iyer; David L Cooper; J Michael Soucie
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

2.  Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh.

Authors:  Mohammed Nadimul Islam; Akhil Ranjon Biswas; Humayra Nazneen; Nobendu Chowdhury; Mahbubul Alam; Jayanta Banik; Md Kamrul Hassan; Abdullah Az Zubayer Khan; Najmul Karim; Mohammad Jahid Hasan; Md Abdullah Saeed Khan
Journal:  Orphanet J Rare Dis       Date:  2022-07-08       Impact factor: 4.303

3.  Plasma levels of IL-1β and IL-37 in patients with severe haemophilia.

Authors:  Pei-Chin Lin; Shyh-Shin Chiou; Wan-Yi Hsu; Yu-Mei Liao; Shih-Pien Tsai; Hsiu-Lan Su; Ping-Tao Lu; Yu-Hsin Tseng
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.